Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

CLOPRETON

Class 5Status: Expired
Application Number327446
Trademark Status
ExpiredRenew Now
Trademark Class5
Application Date1977-07-30
Proprietor Name(1) SUHRID GEIGY LIMITED.Body Incorporate
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameCRAWFORD BAYLEY & CO.[12226]
Agent AddressSTATE BANK BUILDINGS, BANK STREET, FORT, MUMBAI - 400 023.
Goods And Services Details[CLASS : 5] MEDICIANAL AND PHARMACEUTICAL PREPARATIONS.

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
CLOPRETON5Expired
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about CLOPRETON.

What is the status of trademark application 327446?
The current status of trademark application 327446 for CLOPRETON is Expired.
What is the trademark class of CLOPRETON?
CLOPRETON is registered under trademark class 5.
Who is the proprietor of CLOPRETON?
The proprietor of CLOPRETON is (1) SUHRID GEIGY LIMITED.Body Incorporate.
When was trademark application 327446 filed?
Trademark application 327446 for CLOPRETON was filed on 1977-07-30.